Why the study?
Does anti-TNF-alpha monoclonal antibody improve survival and reduce myocardial lesions in a murine model of viral myocarditis?
Population
Four-week-old DBA/2 mice inoculated intraperitoneally with encephalomyocarditis virus to induce viral…
Comparison
Recombinant human TNF-alpha or anti-murine… vs Control group
Design
Preclinical
Follow-up
14 days
Authors
Loading...
Pre-treatment anti-TNF-alpha may attenuate early murine viral myocarditis; hypothesis-generating and should not yet change practice.
Does anti-TNF-alpha monoclonal antibody improve survival and reduce myocardial lesions in a murine model of viral myocarditis?
Anti-TNF-alpha monoclonal antibody may prevent the early pathway of acute viral myocarditis when administered prior to infection in a murine model.
Yamada et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: